• 제목/요약/키워드: TSA

검색결과 245건 처리시간 0.028초

Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A in Osteosarcoma Cells

  • Cheng, Dong-Dong;Yang, Qing-Cheng;Zhang, Zhi-Chang;Yang, Cui-Xia;Liu, Yi-Wen
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권4호
    • /
    • pp.1395-1399
    • /
    • 2012
  • Background: Histone deacetylase (HDAC) inhibitors have been reported to induce cell growth arrest, apoptosis and differentiation of tumor cells. The present study aimed to examine the effects of trichostatin A (TSA), one such inhibitor, on the cell cycle, apoptosis and invasiveness of osteosarcoma cells. Methods: MG-63 cells were treated with TSA at various concentrations. Then, cell growth and apoptosis were determined by 3-(4, 5-dimethyl-2-thiazolyl)-2H-tetrazolium bromide (MTT) and TUNEL assays, respectively; cell cycling was assessed by flow cytometry; invasion assays were performed with the transwell Boyden Chamber system. Results: MTT assays revealed that TSA significantly inhibited the growth of MG-63 cells in a concentration and time dependent manner. TSA treated cells demonstrated morphological changes indicative of apoptosis and TUNEL assays revealed increased apoptosis of MG-63 cells after TSA treatment. Flow cytometry showed that TSA arrested the cell cycle in G1/G2 phase and annexin V positive apoptotic cells increased markedly. In addition, the invasiveness of MG-63 cells was inhibited by TSA in a concentration dependent manner. Conclusion: Our findings demonstrate that TSA inhibits the proliferation, induces apoptosis and inhibits invasiveness of osteosarcoma cells in vitro. HDAC inhibitors may thus have promise to become new therapeutic agents against osteosarcoma.

Optimal stacking sequence design of laminate composite structures using tabu embedded simulated annealing

  • Rama Mohan Rao, A.;Arvind, N.
    • Structural Engineering and Mechanics
    • /
    • 제25권2호
    • /
    • pp.239-268
    • /
    • 2007
  • This paper deals with optimal stacking sequence design of laminate composite structures. The stacking sequence optimisation of laminate composites is formulated as a combinatorial problem and is solved using Simulated Annealing (SA), an algorithm devised based on inspiration of physical process of annealing of solids. The combinatorial constraints are handled using a correction strategy. The SA algorithm is strengthened by embedding Tabu search in order to prevent recycling of recently visited solutions and the resulting algorithm is referred to as tabu embedded simulated Annealing (TSA) algorithm. Computational performance of the proposed TSA algorithm is enhanced through cache-fetch implementation. Numerical experiments have been conducted by considering rectangular composite panels and composite cylindrical shell with different ply numbers and orientations. Numerical studies indicate that the TSA algorithm is quite effective in providing practical designs for lay-up sequence optimisation of laminate composites. The effect of various neighbourhood search algorithms on the convergence characteristics of TSA algorithm is investigated. The sensitiveness of the proposed optimisation algorithm for various parameter settings in simulated annealing is explored through parametric studies. Later, the TSA algorithm is employed for multi-criteria optimisation of hybrid composite cylinders for simultaneously optimising cost as well as weight with constraint on buckling load. The two objectives are initially considered individually and later collectively to solve as a multi-criteria optimisation problem. Finally, the computational efficiency of the TSA based stacking sequence optimisation algorithm has been compared with the genetic algorithm and found to be superior in performance.

Anion Effects on the Aminolysis of Carboxyl-Containing Esters by Triamines in Dimethyl Sulfoxide

  • 서정훈;김용호;장재희
    • Bulletin of the Korean Chemical Society
    • /
    • 제10권1호
    • /
    • pp.72-74
    • /
    • 1989
  • Aminolysis of various carboxyl-containing ester substrates by triamines was kinetically studied in dimethyl sulfoxide (DMSO) in the presence of p-toluenesulfonic acid (TSA) or in the presence of sulfuric acid and potassium iodide (KI). In the presence of TSA or KI, the pseudo-first-order rate constants ($k_o$) were proportional to the total amine concentration ($N_o$). This stands in marked contrast with the corresponding reactions carried out with sulfuric acid added as the sole additive, in which saturation kinetic behavior of ko with respect to No was manifested. This indicates that complex formation between the ester substrate and the amine is greatly suppressed by the addition of TSA or KI. The second-order rate constants obtained in the presence of TSA or KI were substantially greater than those measured in the absence of any additive. These kinetic features were explained in terms of tight interaction between the protonated amines with I- or TSA-. Thus, the results were related to the hydrogen bonding that involves DMSO, bisulfate ion, I-, TSA-, and the protonated forms of triamines.

히스톤탈아세틸효소 억제제 Trichostatin A에 의한 인간 두경부암 셰포주의 방사선 감수성 증강 (Trichostatin A, a Histone Deacetylase Inhibitor, Potentiated Cytotoxic Effect of ionizing Radiation in Human Head and Neck Cancer Cell Lines)

  • 김진호;신진희;지의규;우홍균;김재성;김일한;하성환;박찬일;강위생
    • Radiation Oncology Journal
    • /
    • 제22권2호
    • /
    • pp.138-141
    • /
    • 2004
  • 목적 : 본 연구진이 기왕에 입증한 바 있는 히스톤탈아세틸효소 억제제 trichostatin A (TSA)가 나타내는 방사선 감수성 증강 작용이 두경부암 세포주에서 발생하는 정도를 실험적으로 확인하고자 하였다. 대상 및 방법 : 인간 두경부암 세포주인 HN-3과 HN-9를 0, 50, 100, 200 nM의 TSA에 18시간 동안 전처치시킨 후 각각 0, 2, 4, 6, 8 Gy 방사선을 조사하였다. 세포생존곡선은 clonogenic assay를 이용하여 산출하였고 linear quadratic 모델에 따라 분석하였다 결과 : 방사선 조사 전 TSA처리는 HN-3과 HN-9 세포주의 방사선 감수성을 증강시켰다. 50 nM의 TSA로 처리된 HN-9 세포주에서 2 Gy 조사후 생존분획(SF2)은 유의한 수준으로 감소하였으나, HN-3 세포주는 200 nM의 TSA 처리 후 SF2가 유의하게 감소하였다. HN-3과 HN-9 세포주에서 200 nM TSA의 sensitizer enhancement ratio는 각각 1.84와 7.24였다. 결론 : 방사선 조사 전 히스톤탈아세틸효소 억제는 인간 두경부암 세포주의 방사선 감수성을 증가시켰으며, 이 증강 작용이 암세포주에서의 일반적으로 관찰되는 현상일 가능성이 크다고 제안한다.

Effects of Trichostatin A on In vitro Development of Porcine Embryos Derived from Somatic Cell Nuclear Transfer

  • Jeong, Yeon Ik;Park, Chi Hun;Kim, Huen Suk;Jeong, Yeon Woo;Lee, Jong Yun;Park, Sun Woo;Lee, Se Yeong;Hyun, Sang Hwan;Kim, Yeun Wook;Shin, Taeyoung;Hwang, Woo Suk
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제26권12호
    • /
    • pp.1680-1688
    • /
    • 2013
  • Many different approaches have been developed to improve the efficiency of animal cloning by somatic cell nuclear transfer (SCNT), one of which is to modify histone acetylation levels using histone deacetylase inhibitors (HDACi) such as trichostatin A (TSA). In the present study, we examined the effect of TSA on in vitro development of porcine embryos derived from SCNT. We found that TSA treatment (50 nM) for 24 h following oocyte activation improved blastocyst formation rates (to 22.0%) compared with 8.9% in the non-treatment group and total cell number of the blastocysts for determining embryo quality also increased significantly ($88.9{\rightarrow}114.4$). Changes in histone acetylation levels as a result of TSA treatment were examined using indirect immunofluorescence and confocal microscopy scanning. Results showed that the histone acetylation level in TSA-treated embryos was higher than that in controls at both acetylated histone H3 lysine 9 (AcH3K9) and acetylated histone H4 lysine 12 (AcH4K12). Next, we compared the expression patterns of seven genes (OCT4, ID1; the pluripotent genes, H19, NNAT, PEG1; the imprinting genes, cytokeratin 8 and 18; the trophoblast marker genes). The SCNT blastocysts both with and without TSA treatment showed lower levels of OCT4, ID1, cytokeratin 8 and 18 than those of the in vivo blastocysts. In the case of the imprinting genes H19 and NNAT, except PEG1, the SCNT blastocysts both with and without TSA treatment showed higher levels than those of the in vivo blastocysts. Although the gene expression patterns between cloned blastocysts and their in vivo counterparts were different regardless of TSA treatment, it appears that several genes in NT blastocysts after TSA treatment showed a slight tendency toward expression patterns of in vivo blastocysts. Our results suggest that TSA treatment may improve preimplantation porcine embryo development following SCNT.

Saccharomyces cerevisiae TSA1의 보존된 아스파트산 잔기 및 세린 잔기의 변이가 과산화효소 활성 및 샤페론 활성에 미치는 영향 (Effects of Mutation at Two Conserved Aspartate Residues and a Serine Residue on Functions of Yeast TSA 1)

  • 이송미;조은이;김강화
    • 한국미생물·생명공학회지
    • /
    • 제45권1호
    • /
    • pp.81-86
    • /
    • 2017
  • 퍼옥시레독신은 티오레독신, 티오레독신 환원효소, NADPH로 이루어진 티오레독신 시스템의 환원력을 이용하여 과산화물을 제거하는 티오레독신 과산화효소 활성과 다른 단백질의 열변성에 의한 응집을 막아주는 샤페론 활성을 갖는 효소이다. 정형 2-Cys Prx군에 속하는 퍼옥시레독신 참고서열 1,024개 중 부분적인 서열 등을 제외한 967개 서열을 정렬하였을 때 75번과 103번 아스파트산 잔기는 99% 보존되었고, 73번 세린 잔기는 97% 보존되었음에도 불구하고 잘 보존된 아스파트산 잔기와 세린 잔기에 대해 알려지지 않았다. 이 잔기가 TSA1의 두가지 효소 활성에 미치는 영향을 알아보기 위해 재조합 단백질을 이용하여 활성도를 알아보았다. in vitro 실험을 통하여 잘 보존된 잔기인 103번 아스파트산은 75번 아스파트산보다 티오레독신 퍼옥시레독신 활성 및 분자 샤페론 활성에 더 영향을 미치고, 103번의 음전하는 분자 샤페론 활성에 중요한 역할을 하며 과산화효소활성에는 75번과 103번의 음전하가 관여함을 알 수 있었다. 또한 73의 세린 잔기 역시 과산화효소에 영향을 미치는 잔기임을 알 수 있었다. 최근 출아 효모 퍼옥시레독신인 TSA2의 79번과 109번의 세린 잔기를 시스테인 잔기로 변이시킨 경우 두 변이 단백질 모두 과산화효소 활성과 샤페론 활성이 증가되었는데 이는 ${\beta}$-sheet 구조의 증가와 관련되는 것으로 보고하였다[28]. 이들 두 세린 잔기는 TSA1 구조에 의하면 모두 ${\alpha}$-나선 구조에 위치하였다. 반면에 73번의 세린 잔기는 ${\beta}$-sheet의 C-말단에 위치하는 잔기로 과산화효소 활성에 대한 영향이 다르게 나타나는 것으로 추정된다. 추후 생체 내 실험을 통하여 아스파트산 잔기의 변이가 과산화물 저항성이 미치는 영향 및 열 저항성(thermal stress)에 미치는 역할을 살펴볼 필요가 있다. 또한 아스파트산 잔기와 과산화물과의 반응 및 분자 샤페론과의 반응에 장애가 되는 요인이 무엇인지에 대한 추가 연구가 필요할 것이다.

Histone Deacetylase Inhibitor Trichostatin A Enhances Antitumor Effects of Docetaxel or Erlotinib in A549 Cell Line

  • Zhang, Qun-Cheng;Jiang, Shu-Juan;Zhang, Song;Ma, Xiao-Bin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권7호
    • /
    • pp.3471-3476
    • /
    • 2012
  • Background and Objective: Histone deacetylase (HDAC) inhibitors represent a promising class of potential anticancer agents for treatment of human malignancies. In this study, we investigated the effect of trichostatin A (TSA), one such HDAC inhibitor, in combination with docetaxel (TXT), a cytotoxic chemotherapy agent or erlotinib, a novel molecular target therapy drug, on lung cancer A549 cells. Methods: A549 cells were treated with TXT, erlotinib alone or in combination with TSA, respectively. Cell viability, apoptosis, and cell cycle distribution were evaluated using MTT (3- (4, 5-dimethylthiazol-2-yl) -2, 5-diphenyltetrazolium bromide) assay, Hochst33258 staining and flow cytometry. Moreover, immunofluorescent staining and Western blot analysis were employed to examine alterations of ${\alpha}$-tubulin, heat shock protein 90 (hsp90), epidermal growth factor receptor (EGFR), and caspase-3 in response to the different exogenous stimuli. Results: Compared with single-agent treatment, co-treatment of A549 cells with TSA/TXT or TSA/erlotinib synergistically inhibited cell proliferation, induced apoptosis, and caused cell cycle delay at the $G_2/M$ transition. Treatment with TSA/TXT or TSA/erlotinib led to a significant increase of cleaved caspase-3 expression, also resulting in elevated acetylation of ${\alpha}$-tubulin or hsp90 and decreased expression of EGFR, which was negatively associated with the level of acetylated hsp90. Conclusions: Synergistic anti-tumor effects are observed between TXT or erlotinib and TSA on lung cancer cells. Such combinations may provide a more effective strategy for treating human lung cancer.

Feasibility of Endoscopic Endonasal Approach for Recurrent Pituitary Adenomas after Microscopic Trans-Sphenoidal Approach

  • Hwang, Joo Min;Kim, Yong Hwy;Kim, Jin Wook;Kim, Dong Gyu;Jung, Hee-Won;Chung, Young Seob
    • Journal of Korean Neurosurgical Society
    • /
    • 제54권4호
    • /
    • pp.317-322
    • /
    • 2013
  • Objective : The surgical approach for recurrent pituitary adenoma after trans-sphenoidal approach (TSA) is challenging. We report the outcomes of the endoscopic TSA for recurrent pituitary adenoma after microscopic TSA. Methods : From February 2010 to February 2013, endoscopic TSA was performed for removal of 30 recurrent pituitary adenomas after microscopic TSA. Twenty-seven (90%) patients had a clinically non-functioning pituitary adenoma. Twenty-four (80%) patients suffered from a visual disturbance related to tumor growth. The clinical features and surgical outcomes were retrospectively analyzed for the ophthalmological, endocrinological, and oncological aspects. Results : The mean tumor volume was 11.7 $cm^3$, and gross total resection was achieved in 50% of patients. The volumetric analysis based on the postoperative MR showed that the mean extent of resection rates were 90%. Vision was improved in 19 (79%) of 24 patients with visual symptoms, and endocrinological cure was achieved in all of three functioning pituitary adenomas; however, the post-operative follow-up endocrinological examination revealed a new endocrinological deficit in one patient. Two patients required antibiotics management for post-operative meningitis. Conclusion : The endoscopic TSA can be an effective treatment option for recurrent pituitary adenoma after microscopic TSA with acceptable outcome.

Trichostatin A Modulates Angiotensin II-induced Vasoconstriction and Blood Pressure Via Inhibition of p66shc Activation

  • Kang, Gun;Lee, Yu Ran;Joo, Hee Kyoung;Park, Myoung Soo;Kim, Cuk-Seong;Choi, Sunga;Jeon, ByeongHwa
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제19권5호
    • /
    • pp.467-472
    • /
    • 2015
  • Histone deacetylase (HDAC) has been recognized as a potentially useful therapeutic target for cardiovascular disorders. However, the effect of the HDAC inhibitor, trichostatin A (TSA), on vasoreactivity and hypertension remains unknown. We performed aortic coarctation at the inter-renal level in rats in order to create a hypertensive rat model. Hypertension induced by abdominal aortic coarctation was significantly suppressed by chronic treatment with TSA (0.5 mg/kg/day for 7 days). Nicotinamide adenine dinucleotide phosphate-driven reactive oxygen species production was also reduced in the aortas of TSA-treated aortic coarctation rats. The vasoconstriction induced by angiotensin II (Ang II, 100 nM) was inhibited by TSA in both endothelium-intact and endothelium-denuded rat aortas, suggesting that TSA has mainly acted in vascular smooth muscle cells (VSMCs). In cultured rat aortic VSMCs, Ang II increased p66shc phosphorylation, which was inhibited by the Ang II receptor type I ($AT_1R$) inhibitor, valsartan ($10{\mu}M$), but not by the $AT_2R$ inhibitor, PD123319. TSA ($1{\sim}10{\mu}M$) inhibited Ang II-induced p66shc phosphorylation in VSMCs and in HEK293T cells expressing $AT_1R$. Taken together, these results suggest that TSA treatment inhibited vasoconstriction and hypertension via inhibition of Ang II-induced phosphorylation of p66shc through $AT_1R$.

Trichostatin A Induces Apoptotic Cell Death in Human Breast Carcinoma Cells through Activation of Caspase-3

  • Kim, Nsm-Deuk;Kim, Seaho;Choi, Yung-Hyun;Im, Eun-Ok;Lee, Ji-Hyeon;Kim, Dong-Kyoo
    • Journal of Life Science
    • /
    • 제10권2호
    • /
    • pp.39-44
    • /
    • 2000
  • Trichostatin A (TSA) is a Streptomyces product, which inhibits the enzyme activity of histone deacetylase. It is also known as an inducer of apoptosis in several human cancer cell lines. In this study, we investigated the mechanism of apoptosis induced by TSA in MDA-MB-231 human breast carcinoma cells. The cytotoxicity of TSA on MDA-MB-231 cells was assessed by MTT assay. The cell viability was decreased dose-dependently and the IC\ulcorner value was about 100 ng/ml after 48 h treatment with TSA. Morphological change and DNA ladder formation, the biochemical hallmarks of apoptotic cell death, were observed after treatment of TSA in a concentration-dependent manner, which was accompanied with cleavage of poly(ADP-ribose) polymerase and $\beta$-catenin, and activation of caspase-3. TSA treatment up-regulated the expression of a cyclin-dependent kinase inhibitor p21 (Wafl/Cip1) protein, a key regulatory protein of the cell cycle. However, there is no detectable change of both Bcl-2 and Bax expressions. These results demonstrated that TSA might inhibit cell growth through apoptosis in human breast carcinoma MDA-MB-231 cells.

  • PDF